Literature DB >> 20852946

PALB2: a novel inactivating mutation in a Italian breast cancer family.

Cristina Balia1, Elisa Sensi, Grazia Lombardi, Manuela Roncella, Generoso Bevilacqua, Maria Adelaide Caligo.   

Abstract

Rare germline monoallelic mutations in PALB2 confer a relative risk of breast cancer of 2 to 4-times. To better define the role of PALB2 in breast cancer susceptibility in Italian breast or breast-ovarian cancer families we screened 95 index cases negative for BRCA1/BRCA2 germline mutations. The mutational analysis of the PALB2 gene in a index case of an high risk breast cancer family, has identified a frameshift mutation (c.1517delG) in the exon 4 that leads to the formation of a stop codon, 12 residues downstream of the mutation (Leu451X). The mutation was identified in a woman 52 year old with an infiltrating ductal breast carcinoma and in two of the three sisters without breast cancer. Our results confirmed that PALB2 could be a susceptibility gene for familial breast cancer also in Italian population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20852946     DOI: 10.1007/s10689-010-9382-1

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  19 in total

1.  Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.

Authors:  Bing Xia; Josephine C Dorsman; Najim Ameziane; Yne de Vries; Martin A Rooimans; Qing Sheng; Gerard Pals; Abdellatif Errami; Eliane Gluckman; Julian Llera; Weidong Wang; David M Livingston; Hans Joenje; Johan P de Winter
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

2.  PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations.

Authors:  Jin Ho Kim; Doo Ho Choi; Dae Yeon Cho; Sei Hyun Ahn; Byung Ho Son; Bruce G Haffty
Journal:  Breast Cancer Res Treat       Date:  2010-03-06       Impact factor: 4.872

Review 3.  Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins.

Authors:  Weidong Wang
Journal:  Nat Rev Genet       Date:  2007-09-04       Impact factor: 53.242

4.  A recurrent mutation in PALB2 in Finnish cancer families.

Authors:  Hannele Erkko; Bing Xia; Jenni Nikkilä; Johanna Schleutker; Kirsi Syrjäkoski; Arto Mannermaa; Anne Kallioniemi; Katri Pylkäs; Sanna-Maria Karppinen; Katrin Rapakko; Alexander Miron; Qing Sheng; Guilan Li; Henna Mattila; Daphne W Bell; Daniel A Haber; Mervi Grip; Mervi Reiman; Arja Jukkola-Vuorinen; Aki Mustonen; Juha Kere; Lauri A Aaltonen; Veli-Matti Kosma; Vesa Kataja; Ylermi Soini; Ronny I Drapkin; David M Livingston; Robert Winqvist
Journal:  Nature       Date:  2007-02-07       Impact factor: 49.962

5.  A PALB2 germline mutation associated with hereditary breast cancer in Italy.

Authors:  Laura Papi; Anna Laura Putignano; Caterina Congregati; Irene Piaceri; Ines Zanna; Francesco Sera; Doralba Morrone; Maurizio Genuardi; Domenico Palli
Journal:  Fam Cancer       Date:  2009-09-18       Impact factor: 2.375

6.  PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2.

Authors:  Fan Zhang; Qiang Fan; Keqin Ren; Paul R Andreassen
Journal:  Mol Cancer Res       Date:  2009-07-07       Impact factor: 5.852

7.  Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.

Authors:  María J García; Victoria Fernández; Ana Osorio; Alicia Barroso; Gemma Llort; Conxi Lázaro; Ignacio Blanco; Trinidad Caldés; Miguel de la Hoya; Teresa Ramón Y Cajal; Carmen Alonso; María-Isabel Tejada; Carlos San Román; Luis Robles-Díaz; Miguel Urioste; Javier Benítez
Journal:  Breast Cancer Res Treat       Date:  2008-02-27       Impact factor: 4.872

8.  PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.

Authors:  Nazneen Rahman; Sheila Seal; Deborah Thompson; Patrick Kelly; Anthony Renwick; Anna Elliott; Sarah Reid; Katarina Spanova; Rita Barfoot; Tasnim Chagtai; Hiran Jayatilake; Lesley McGuffog; Sandra Hanks; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

9.  Analysis of PALB2/FANCN-associated breast cancer families.

Authors:  Marc Tischkowitz; Bing Xia; Nelly Sabbaghian; Jorge S Reis-Filho; Nancy Hamel; Guilan Li; Erik H van Beers; Lili Li; Tayma Khalil; Louise A Quenneville; Atilla Omeroglu; Aletta Poll; Pierre Lepage; Nora Wong; Petra M Nederlof; Alan Ashworth; Patricia N Tonin; Steven A Narod; David M Livingston; William D Foulkes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

10.  Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women.

Authors:  William D Foulkes; Parviz Ghadirian; Mohammed Reza Akbari; Nancy Hamel; Sylvie Giroux; Nelly Sabbaghian; Andrew Darnel; Robert Royer; Aletta Poll; Eve Fafard; André Robidoux; Ginette Martin; Tarek A Bismar; Marc Tischkowitz; Francois Rousseau; Steven A Narod
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more
  15 in total

1.  Novel germline PALB2 truncating mutations in African American breast cancer patients.

Authors:  Yonglan Zheng; Jing Zhang; Qun Niu; Dezheng Huo; Olufunmilayo I Olopade
Journal:  Cancer       Date:  2011-08-26       Impact factor: 6.860

2.  Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families.

Authors:  Irene Catucci; Roni Milgrom; Anya Kushnir; Yael Laitman; Shani Paluch-Shimon; Sara Volorio; Filomena Ficarazzi; Loris Bernard; Paolo Radice; Eitan Friedman; Paolo Peterlongo
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

3.  Analysis of PALB2 in a cohort of Italian breast cancer patients: identification of a novel PALB2 truncating mutation.

Authors:  Maria Teresa Vietri; Gemma Caliendo; Concetta Schiano; Amelia Casamassimi; Anna Maria Molinari; Claudio Napoli; Michele Cioffi
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

4.  Germline mutations in PALB2 in African-American breast cancer cases.

Authors:  Yuan Chun Ding; Linda Steele; Li-Hao Chu; Karen Kelley; Helen Davis; Esther M John; Gail E Tomlinson; Susan L Neuhausen
Journal:  Breast Cancer Res Treat       Date:  2010-11-27       Impact factor: 4.872

5.  Association of PALB2 sequence variants with the risk of early-onset breast cancer in patients from Turkey.

Authors:  G Cecener; G Guney Eskiler; U Egeli; B Tunca; A Alemdar; S Gokgoz; I Tasdelen
Journal:  Mol Biol Rep       Date:  2016-08-29       Impact factor: 2.316

6.  Prevalence of PALB2 mutation c.509_510delGA in unselected breast cancer patients from Central and Eastern Europe.

Authors:  Monika Noskowicz; Natalia Bogdanova; Marina Bermisheva; Zalina Takhirova; Natalia Antonenkova; Elza Khusnutdinova; Michael Bremer; Hans Christiansen; Tjoung-Won Park-Simon; Peter Hillemanns; Thilo Dörk
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

7.  Sequencing analysis of SLX4/FANCP gene in Italian familial breast cancer cases.

Authors:  Irene Catucci; Mara Colombo; Paolo Verderio; Loris Bernard; Filomena Ficarazzi; Frederique Mariette; Monica Barile; Bernard Peissel; Elisa Cattaneo; Siranoush Manoukian; Paolo Radice; Paolo Peterlongo
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

8.  PALB2 mutations in German and Russian patients with bilateral breast cancer.

Authors:  Natalia Bogdanova; Anna P Sokolenko; Aglaya G Iyevleva; Svetlana N Abysheva; Magda Blaut; Michael Bremer; Hans Christiansen; Margret Rave-Fränk; Thilo Dörk; Evgeny N Imyanitov
Journal:  Breast Cancer Res Treat       Date:  2010-12-17       Impact factor: 4.872

9.  Inherited and acquired alterations in development of breast cancer.

Authors:  Piera Rizzolo; Valentina Silvestri; Mario Falchetti; Laura Ottini
Journal:  Appl Clin Genet       Date:  2011-11-14

10.  Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls.

Authors:  Ella R Thompson; Kylie L Gorringe; Simone M Rowley; Michelle W Wong-Brown; Simone McInerny; Na Li; Alison H Trainer; Lisa Devereux; Maria A Doyle; Jason Li; Richard Lupat; Martin B Delatycki; Gillian Mitchell; Paul A James; Rodney J Scott; Ian G Campbell
Journal:  Breast Cancer Res       Date:  2015-08-19       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.